ZURICH, May 22, 2024 /PRNewswire/ — Swiss life science innovation will again be on display at the BIO 2024 convention in San Diego. Switzerland Global Enterprise will present 41 leading Swiss biotech stars at the SWISS BIOTECH pavilion demonstrating Switzerland’s key role in the healthcare sector.
The companies presenting at this year’s conference show a wide range of innovative solutions from drug discovery, leveraging AI for data analytics to clinical trial management and pharmaceutical consulting services.
The Swiss Biotech industry once more generated record revenues, driven by collaboration and licensing deals. Swiss biotech companies often successfully partner with large pharma companies and thanks to record numbers of approvals from Swissmedic, EMA, FDA, and other global regulatory authorities, product sales got a big boost. Meanwhile, public funding remains dire, private funding kept up the pace from 2023.
“With its R&D and manufacturing capacity far exceeding its own needs, Switzerland has established itself as a trusted partner in bilateral and multilateral alliances,” Michael Altorfer CEO, Swiss Biotech Association.
Along with their partners, the Swiss Biotech Association, InnoSuisse and, Switzerland Global Enterprise and their representatives in the US, the Swiss Business Hub USA bring the leading-edge innovation that Switzerland is consistently recognized for to BIO 2024.
Switzerland Global Enterprise with its partner Swissnex in Boston and New York will be hosting a Swiss reception on Tuesday June 4th from 5pm to 6:30pm at the Swiss Pavilion, booth #2111.
|
• AliraHealth |
Alira Health provides global consulting and clinical services |
|
• ariadne.ai ag |
Specializes in leveraging artificial intelligence for advanced data |
|
• Bacthera SA |
Focuses on the manufacture of live biotherapeutic products |
|
• BioAlps Association |
Acts as a life sciences cluster promoting networking and |
|
• Bioengineering AG |
Provides solutions in bioprocess engineering, ranging |
|
• Biopôle SA |
Operates a life sciences campus that supports innovation |
|
• BioVersys AG |
Engages in the research and development of drugs that |
|
• Business Location Switzerland |
Promotes Switzerland as a prime location for business |
|
• DiNABIOS a DiNAQOR Group Company |
Specializes in innovative therapies for patients with |
|
• EPIC Suisse Property Management GmbH |
Offers comprehensive property management services |
|
• InSphero AG |
Develops and produces 3D microtissues for drug |
|
• Kisco Pharma Outsourcing Solutions |
Provides outsourcing solutions for pharmaceutical |
|
• KPMG |
Offers audit, tax, and advisory services to help |
|
• Molecular Partners AG |
Develops a new class of custom-built protein therapeutics |
|
• Novigenix |
Focuses on developing and commercializing blood tests |
|
• Obaris AG |
Specializes in the development and commercialization of |
|
• OM Pharma |
Engages in the research, development, and marketing of |
|
• PDC Therapeutics |
Focuses on developing precision drugs for the treatment |
|
• Superlab Suisse AG |
Provides high-tech laboratory services and research |
|
• Tigermed Swiss SA |
Offers clinical trial management and pharmaceutical |
|
• Venture Valuation Inc. |
Specializes in the assessment and valuation of growth |
|
• Amphilix |
Focuses on innovative technologies for biopharmaceutical |
|
• Cellestia Biotech AG |
Specializes in developing targeted therapies for cancer |
|
• Cellvie |
Dedicated to advancing mitochondrial transplantation |
|
• FluoSphera |
Provides high-throughput screening services using |
|
• Nagi Bioscience |
Develops the first Organism-on-Chip technology for |
|
• REM Analytics SA |
Specializes in microbiome analytics and solutions for |
|
• Scailyte |
Uses single-cell technologies and AI-driven data analysis |
|
• Synendos Therapeutics AG |
Focuses on the development of breakthrough therapies |
|
• Vandria |
Offers digital solutions to enhance the efficiency and |
|
• Alpha Onco |
Engages in the development of innovative oncology |
|
• BioArk |
Provides infrastructure and support for startups and |
|
• Ceidos SA |
Specializes in virtual reality solutions, primarily for |
|
• Curio Biotech SA |
Focuses on developing novel treatments based on cell |
|
• Excellgene |
Produces biopharmaceuticals using advanced cell line |
|
• Immunskills |
Offers workshops and training in immunotherapy and |
|
• Novochizol SA |
Develops chitosan-based formulations to enhance the |
|
• Orio Therapeutics |
Specializes in developing therapies for respiratory |
|
• SETI / Canton VS |
Supports economic development in Valais, particularly in |
|
• Stämm Biotech |
Works on bioprocesses that utilize human stem cells for |
|
• Swiss Biotech Center |
Provides laboratory services, R&D, and consulting to |
|
• ten23 health Valais Ltd. |
Offers services in drug development and manufacturing, |
The SWISS BIOTECH companies will be available for media and partner interviews the entire week.
www.s-ge.com
About Switzerland Global Enterprise
Switzerland Global Enterprise (S-GE) is the official Swiss organization for export and investment promotion with around 200 employees at locations throughout Switzerland and overseas. S-GE supports Swiss SMEs in their international business and helps innovative foreign companies to settle in Switzerland. In doing so, we rely on a unique network of national and international partners. This allows us to create added value for our customers and prosperity for Switzerland. As a non-profit organization, we provide a public service for our clients on behalf of the Swiss Confederation (State Secretariat for Economic Affairs SECO) and the cantons. We operate our 27 offices, the so-called Swiss Business Hubs, and Trade Points, in 31 countries jointly with the Federal Department of Foreign Affairs (FDFA). Thanks to our global network of partners, we also support our customers in many other countries.
SOURCE Swiss Business Hub USA
